Skeptic critique for analysis 8ec36980-febb-4093-a5a1-387ea5768480: Proteogenomic Network Hubs as Druggable Targets in Early PD Neurodegeneration
The source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Key genes and convergent pathogenic mechanisms in Parkinson disease could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: network hubs are often essential, pleiotropic, or inaccessible to safe pharmacologic modulation.
The debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing early PD proteogenomic hubs that are both causal enough and accessible enough to perturb in the disease-relevant model, even when technical power and cell-state annotation are adequate.
The strongest alternative explanation is that SNCA mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.